Anti-clastogenic effect of magnolol-containing Hange-koboku-to, Dai-joki-to, Goshaku-san, and Magnoliae Cortex on benzo(a)pyrene-induced clastogenicity in mice

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 7, 2009, Pages 1209-1214

  Saito, Junichiro ^a   Fukushima, Hiroko ^b   Nagase, Hisamitsu ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Anti clastogenic effect; Dai joki to; Goshaku san; Hange koboku to; Magnoliae Cortex; Magnolol

Indexed keywords

ACRIDINE ORANGE; BENZO[A]PYRENE; CYTOCHROME P450 1A1; ENVIRONMENTAL MUTAGEN; KAMPO; MAGNOLOL; ZOXAZOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD; DAI JOKI TO; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; GENOTOXICITY; GOSHAKU SAN; HANGE KOBOKU TO; LOW DRUG DOSE; MAGNOLIACEAE; MAGNOLIAE CORTEX; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PARALYSIS; TRADITIONAL MEDICINE;

ANIMALS; ANTIMUTAGENIC AGENTS; BENZO(A)PYRENE; BIPHENYL COMPOUNDS; CYTOCHROME P-450 CYP1A1; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; LIGNANS; MAGNOLIA; MEDICINE, KAMPO; MICE; MICE, INBRED ICR; MICRONUCLEUS TESTS; MUTAGENS; PLANT BARK;

EID: 67650759759     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1209     Document Type: Article

References (24)

1. Saito J., Sakai Y., Nagase H., Mutat. Res., 609, 68-73 (2006).
2. Saito J., Shibuya K., Nagase H., Food Chem. Toxicol., 46, 694-700 (2008).
3. Saito J., Fukushima H., Nagase H., Phytother. Res. (in press).
4. Teng C. M., Chen C. C., Ko F. N., Lee L. G., Huang T. F., Chen Y. P., Hsu H. Y., Thromb. Res., 50, 757-765 (1988).
5. Fujita S., Taira J., Free Radic. Biol. Med., 17, 273-277 (1994).
6. Teng C. M., Yu S. M., Chen C. C., Huang Y. L., Huang T. F., Life Sci., 47, 1153-1161 (1990).
7. Wang J. P., Ho T. F., Chang L. C., Chen C. C., J. Pharm. Pharmacol., 47, 857-860 (1995).
8. Nagase H., Ikeda K., Sakai Y., Planta Med., 67, 705-708 (2001).
9. Ikeda K., Nagase H., Biol. Pharm. Bull., 25, 1546-1549 (2002).
10. Konoshima T., Kozuka M., Tokuda H., Nishino H., Iwashima A., Haruna M., Ito K., Tanabe M., J. Nat. Prod., 54, 816-822 (1991).
11. Lin Y. R., Chen H. H., Ko C. H., Chan M. H., Life Sci., 81, 1071-1078 (2007).
12. Han S. J., Bae E. A., Trinh H. T., Yang J. H., Youn U. J., Kim D. H., Biol. Pharm. Bull., 30, 2201-2203 (2007).
13. Yang T. C., Zhang S. W., Sun L. N., Wang H., Ren A. M., World J. Gastroenterol., 14, 7353-7360 (2008).
14. Lijinsky W., Mutat. Res., 259, 251-261 (1991).
15. Pal K., Grover P. L., Sims P., Mutat. Res., 78, 193-199 (1980).
16. Kliesch U., Roupova J., Adler I. D., Mutat. Res., 102, 265-273 (1982).
17. Mersch-Sundermann V., Mochayedi S., Kevekordes S., Mutat. Res., 278, 1-9 (1992).
18. MacLeod M. C., Daylong A., Adair G., Humphrey R. M., Mutat. Res., 261, 267-279 (1991).
19. Hayashi M., Morita T., Kodama Y., Sofuni T., Ishidate Jr. M., Mutat. Res., 245, 245-249 (1990).
20. Conney A. H., Davison C., Gastel R., Burns J. J., J. Pharmacol. Exp. Ther., 130, 1-8 (1960).
21. Park W. H., Lee S. K., Oh H. K., Bae J. Y., Kim C. H., Immunopharmacol. Immunotoxicol., 27, 473-483 (2005).
22. Manju V., Nalini N., Clin. Chim. Acta, 358, 60-67 (2005).
23. Ueda H., Yamazaki C., Yamazaki M., Biol. Pharm. Bull., 26, 560-563 (2003).
24. Kim K. B., Lee B. M., Cancer Lett., 113, 205-212 (1997).